Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
ABSTRACT Denosumab has been used successfully to treat disease‐associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central giant cell granuloma (CGCG), aneurysma...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019-10-01
|
| Seri Bilgileri: | JBMR Plus |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/jbm4.10210 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|